Premium
Rapid update on childhood immune thrombocytopenic purpure
Author(s) -
Cole Catherine H
Publication year - 2012
Publication title -
journal of paediatrics and child health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.631
H-Index - 76
eISSN - 1440-1754
pISSN - 1034-4810
DOI - 10.1111/j.1440-1754.2011.02207.x
Subject(s) - medicine , limiting , immune system , pediatrics , anxiety , prospective cohort study , quality of life (healthcare) , intensive care medicine , immunology , psychiatry , mechanical engineering , nursing , engineering
Most childhood immune thrombocytopenic purpure is benign, self‐limiting and requires no therapy. However, questions remain: (i) to treat or not; (ii) bone marrow examination or not; and (iii) admit to hospital or not. These questions have dominated the literature and we still need a prospective large multi‐centre study of these issues to determine a useful bleeding score, quality of life measure and a measure of parental anxiety.